GPT and liver disorder: We then confirmed the clinical relevance of the reference limits for ALT, AST, and GGT through external validation against incident MALOs in a combined dataset of three general population cohorts, spanning different time periods and including participants without baseline clinical liver disease, with no additional selection criteria.